Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286615290> ?p ?o ?g. }
- W4286615290 endingPage "2260" @default.
- W4286615290 startingPage "2252" @default.
- W4286615290 abstract "Polypharmacology is a new trend in amyotrophic lateral sclerosis (ALS) therapy and an effective way of addressing a multifactorial etiology involving excitotoxicity, mitochondrial dysfunction, oxidative stress, and microglial activation. Inspired by a reported clinical trial, we converted a riluzole (1)-rasagiline (2) combination into single-molecule multi-target-directed ligands. By a ligand-based approach, the highly structurally integrated hybrids 3-8 were designed and synthesized. Through a target- and phenotypic-based screening pipeline, we identified hit compound 6. It showed monoamine oxidase A (MAO-A) inhibitory activity (IC50 = 6.9 μM) rationalized by in silico studies as well as in vitro brain permeability. By using neuronal and non-neuronal cell models, including ALS-patient-derived cells, we disclosed for 6 a neuroprotective/neuroinflammatory profile similar to that of the parent compounds and their combination. Furthermore, the unexpected MAO inhibitory activity of 1 (IC50 = 8.7 μM) might add a piece to the puzzle of its anti-ALS molecular profile." @default.
- W4286615290 created "2022-07-23" @default.
- W4286615290 creator A5002330965 @default.
- W4286615290 creator A5002660712 @default.
- W4286615290 creator A5008583952 @default.
- W4286615290 creator A5011323357 @default.
- W4286615290 creator A5020565284 @default.
- W4286615290 creator A5022120195 @default.
- W4286615290 creator A5023447406 @default.
- W4286615290 creator A5033718762 @default.
- W4286615290 creator A5035724638 @default.
- W4286615290 creator A5037562938 @default.
- W4286615290 creator A5041651428 @default.
- W4286615290 creator A5048846660 @default.
- W4286615290 creator A5049860298 @default.
- W4286615290 creator A5052207161 @default.
- W4286615290 creator A5056958082 @default.
- W4286615290 creator A5068000809 @default.
- W4286615290 creator A5069833831 @default.
- W4286615290 creator A5070226332 @default.
- W4286615290 creator A5072661653 @default.
- W4286615290 creator A5073165405 @default.
- W4286615290 creator A5076906551 @default.
- W4286615290 creator A5083697878 @default.
- W4286615290 creator A5087723546 @default.
- W4286615290 creator A5090475908 @default.
- W4286615290 date "2022-07-22" @default.
- W4286615290 modified "2023-10-14" @default.
- W4286615290 title "Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis" @default.
- W4286615290 cites W1722132302 @default.
- W4286615290 cites W1966987284 @default.
- W4286615290 cites W1969617718 @default.
- W4286615290 cites W1970433280 @default.
- W4286615290 cites W1978688182 @default.
- W4286615290 cites W1981657815 @default.
- W4286615290 cites W1981775239 @default.
- W4286615290 cites W1984133190 @default.
- W4286615290 cites W1996024251 @default.
- W4286615290 cites W2001298537 @default.
- W4286615290 cites W2005614483 @default.
- W4286615290 cites W2009080781 @default.
- W4286615290 cites W2014047273 @default.
- W4286615290 cites W2016575780 @default.
- W4286615290 cites W2024637155 @default.
- W4286615290 cites W2026976753 @default.
- W4286615290 cites W2045357777 @default.
- W4286615290 cites W2054984659 @default.
- W4286615290 cites W2056837063 @default.
- W4286615290 cites W2057538103 @default.
- W4286615290 cites W2083968759 @default.
- W4286615290 cites W2093781635 @default.
- W4286615290 cites W2131770496 @default.
- W4286615290 cites W2317110841 @default.
- W4286615290 cites W2463139428 @default.
- W4286615290 cites W2592775972 @default.
- W4286615290 cites W2749944343 @default.
- W4286615290 cites W2785812680 @default.
- W4286615290 cites W2805797484 @default.
- W4286615290 cites W2809205405 @default.
- W4286615290 cites W2891450312 @default.
- W4286615290 cites W2898531791 @default.
- W4286615290 cites W2913609543 @default.
- W4286615290 cites W2964612779 @default.
- W4286615290 cites W3012196581 @default.
- W4286615290 cites W3045259572 @default.
- W4286615290 cites W3136115014 @default.
- W4286615290 cites W3209068501 @default.
- W4286615290 cites W3216005154 @default.
- W4286615290 cites W4206457055 @default.
- W4286615290 cites W4224438357 @default.
- W4286615290 doi "https://doi.org/10.1021/acschemneuro.2c00261" @default.
- W4286615290 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35868251" @default.
- W4286615290 hasPublicationYear "2022" @default.
- W4286615290 type Work @default.
- W4286615290 citedByCount "0" @default.
- W4286615290 crossrefType "journal-article" @default.
- W4286615290 hasAuthorship W4286615290A5002330965 @default.
- W4286615290 hasAuthorship W4286615290A5002660712 @default.
- W4286615290 hasAuthorship W4286615290A5008583952 @default.
- W4286615290 hasAuthorship W4286615290A5011323357 @default.
- W4286615290 hasAuthorship W4286615290A5020565284 @default.
- W4286615290 hasAuthorship W4286615290A5022120195 @default.
- W4286615290 hasAuthorship W4286615290A5023447406 @default.
- W4286615290 hasAuthorship W4286615290A5033718762 @default.
- W4286615290 hasAuthorship W4286615290A5035724638 @default.
- W4286615290 hasAuthorship W4286615290A5037562938 @default.
- W4286615290 hasAuthorship W4286615290A5041651428 @default.
- W4286615290 hasAuthorship W4286615290A5048846660 @default.
- W4286615290 hasAuthorship W4286615290A5049860298 @default.
- W4286615290 hasAuthorship W4286615290A5052207161 @default.
- W4286615290 hasAuthorship W4286615290A5056958082 @default.
- W4286615290 hasAuthorship W4286615290A5068000809 @default.
- W4286615290 hasAuthorship W4286615290A5069833831 @default.
- W4286615290 hasAuthorship W4286615290A5070226332 @default.
- W4286615290 hasAuthorship W4286615290A5072661653 @default.
- W4286615290 hasAuthorship W4286615290A5073165405 @default.
- W4286615290 hasAuthorship W4286615290A5076906551 @default.
- W4286615290 hasAuthorship W4286615290A5083697878 @default.